Recombinant Suid herpesvirus 1 Varicella zoster virus Protein (Yeast)，His

Varicella zoster virus (VZV) is a member of the Herpesviridae family and is responsible for causing chickenpox (varicella) in children and shingles (zoster) in adults. After initial infection, VZV remains dormant in the sensory neurons and can reactivate later in life, leading to painful zoster outbreaks. The development of effective vaccines and antiviral therapies is crucial for managing these conditions. In recent years, research has increasingly focused on the use of recombinant proteins derived from VZV to enhance immune responses. These recombinant proteins, which may include glycoproteins and other viral components, can serve as potential candidates for vaccine development or diagnostic assays. Understanding the immunogenic properties of these proteins can help in designing more effective vaccines that can elicit robust and long-lasting immunity. Additionally, recombinant protein studies can provide insights into the mechanisms of VZV pathogenesis and the host immune response, which are essential for developing targeted therapies. As such, the exploration of VZV recombinant proteins represents a promising avenue for advancing our strategies against VZV-related diseases, ultimately aiming to reduce the incidence and severity of varicella and zoster in populations worldwide.